{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:23:44Z","timestamp":1780363424339,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ad.2025.104493","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:26:19Z","timestamp":1764779179000},"page":"104493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-Term Real-World Persistence of Guselkumab in Patients With Moderate-to-Severe Psoriasis"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-4208","authenticated-orcid":false,"given":"J.","family":"Borr\u00e1s-Blasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Valcuende-Rosique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2025.104493_bib0055","article-title":"Persistence, current state of the art","author":"Rodriguez Goicoechea","year":"2023","journal-title":"Farm Hosp"},{"key":"10.1016\/j.ad.2025.104493_bib0060","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/jdv.15600","article-title":"Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis","volume":"33","author":"De la Cueva Dobao","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2025.104493_bib0065","first-page":"62","article-title":"Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease","volume":"44","author":"Calvo-Arbeloa","year":"2020","journal-title":"Farm Hosp"},{"key":"10.1016\/j.ad.2025.104493_bib0070","article-title":"El valor de la persistencia en el modelo de la Medicina 5P en enfermedades cr\u00f3nicas","author":"Borras-Blasco","year":"2023","journal-title":"J Healthc Qual Res"},{"key":"10.1016\/j.ad.2025.104493_bib0075","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-022-00722-y","article-title":"Drug survival of interleukin (IL) 17 and il 23 inhibitors for the treatment of psoriasis: a retrospective multi country multicentric cohort study","volume":"23","author":"Torres","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2025.104493_bib0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2016.11.042","volume":"76","author":"Reich","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2025.104493_bib0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ad.2023.10.023","article-title":"Efficacy and pharmacoeconomic analysis in real clinical practice conditions of patients with plaque psoriasis treated with guselkumab: a retrospective multicenter study","volume":"115","author":"Ruiz-Villaverde","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2025.104493_bib0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40261-023-01280-9","article-title":"Real-world performance of a new strategy for off-label use of guselkumab in moderate to severe psoriasis: super-responder patients as the epitome of efficacy and optimisation","volume":"43","author":"Herranz-Pinto","year":"2023","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ad.2025.104493_bib0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/14712598.2023.2194485","article-title":"Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks","volume":"23","author":"Galluzzo","year":"2023","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ad.2025.104493_bib0100","doi-asserted-by":"crossref","DOI":"10.1093\/intqhc\/mzae026","article-title":"Integration of persistence in the 5P-medicine approach for age-related chronic diseases","volume":"36","author":"Borr\u00e1s-Blasco","year":"2024","journal-title":"Int J Qual Health Care"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025007628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025007628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T13:31:37Z","timestamp":1769261497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731025007628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0001731025007628"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2025.104493","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Real-World Persistence of Guselkumab in Patients With Moderate-to-Severe Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2025.104493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104493"}}